ORMP
Oramed Pharmaceuticals Inc
4.70$
+1.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.9% | 65.9% | 72.9% | 52.4% | 65.5% | 96.1% | 90.8% | 74.5% | 97.2% | 73.7% | 92.2% | 57.7% | |
| 8.1% | 12.2% | 9.1% | 10.3% | 10.5% | 9.6% | 43.2% | 60.3% | 25.0% | 4.1% | 35.0% | 19.9% | |
| 97.7% | 65.4% | 72.4% | 52.0% | 64.3% | 93.1% | 89.4% | 73.5% | 96.3% | 73.5% | 91.4% | 54.5% | |
| 1.9% | – | – | – | – | – | – | – | – | – | – | 2.0% | |
| 0.1% | – | – | – | – | – | – | – | – | – | – | – | |
| 4.6% | 5.8% | 38.9% | 50.3% | 34.4% | 44.1% | 26.3% | 9.0% | 6.5% | 26.1% | 6.4% | 13.5% | |
| 4.5% | 5.6% | 8.5% | 13.3% | 9.6% | 15.3% | 10.2% | 5.2% | 3.6% | 24.1% | 3.7% | 8.3% | |
| – | – | – | – | – | – | 0.1% | 0.1% | 0.2% | 23.3% | 0.1% | 0.1% | |
| 4.2% | 3.6% | 3.3% | 1.5% | 2.4% | 3.9% | 1.3% | 2.0% | 1.3% | 0.2% | 0.5% | 0.2% | |
| 95.4% | 94.2% | 61.1% | 49.7% | 65.6% | 55.9% | 73.7% | 90.4% | 93.9% | 74.3% | 94.2% | 86.5% | |
| -127.6% | -133.0% | -107.4% | -145.9% | -146.0% | -234.0% | -207.5% | -89.7% | -100.9% | -71.4% | -113.7% | -53.5% | |
| 42.4% | 41.1% | 29.5% | 34.4% | 31.4% | 50.4% | 46.0% | 22.2% | 24.1% | 18.4% | 26.3% | 18.4% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.